COGT logo

Cogent Biosciences, Inc. (COGT) Accounts Receivable

Annual Accounts Receivable:

N/A
December 31, 2024

Summary

  • COGT annual accounts receivable is not available.

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

COGT Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-Time High

$2.00M
COGT annual accounts receivable is currently at an all-time high

3-Year Low

-
COGT annual accounts receivable 3-year low is unknown

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
COGT previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
COGT next annual earnings announcement has not yet been scheduled

OtherCOGTbalance sheet metrics

Annual Accounts Payable

$12.01M
COGT annual accounts payable is $12.01 million

Annual Total Assets

$327.90M
COGT annual total assets is $327.90 million

Annual Total Liabilities

$71.61M
COGT annual total liabilities is $71.61 million

Annual Cash & Cash Equivalents

$287.08M
COGT annual cash & cash equivalents is $287.08 million

Quarterly Accounts Receivable:

N/A
June 30, 2025

Summary

  • COGT quarterly accounts receivable is not available.

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

COGT Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-Time High

$2.04M
COGT quarterly accounts receivable is currently at an all-time high

3-Year Low

-
COGT quarterly accounts receivable 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
COGT previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 10, 2025
COGT next earnings announcement is scheduled for Nov 10, 2025

OtherCOGTbalance sheet metrics

Quarterly Accounts Payable

$16.63M
COGT quarterly accounts payable is $16.63 million

Quarterly Total Assets

$274.82M
COGT quarterly total assets is $274.82 million

Quarterly Total Liabilities

$119.78M
COGT quarterly total liabilities is $119.78 million

Quarterly Cash & Cash Equivalents

$237.85M
COGT quarterly cash & cash equivalents is $237.85 million

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

COGT Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year--
3Y3 Years--
5Y5 Years--

COGT Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year
5Y5-Year
All-TimeAll-Time

COGT Accounts Receivable History

DateAnnualQuarterly
Dec 2020
$0.00(-100.0%)
$0.00(0.0%)
Sep 2020
-
$0.00(0.0%)
Jun 2020
-
$0.00(0.0%)
Mar 2020
-
$0.00(-100.0%)
Dec 2019
$2.00M(+19.9%)
$2.00M(+127.3%)
Sep 2019
-
$880.00K(-41.0%)
Jun 2019
-
$1.49M(-26.9%)
Mar 2019
-
$2.04M(+22.3%)
DateAnnualQuarterly
Dec 2018
$1.67M(+101.0%)
$1.67M(+17.5%)
Sep 2018
-
$1.42M(+18.1%)
Jun 2018
-
$1.20M(-24.9%)
Mar 2018
-
$1.60M(+92.9%)
Dec 2017
$830.00K(-10.6%)
$830.00K(-45.1%)
Sep 2017
-
$1.51M
Dec 2016
$928.00K(+215.6%)
-
Dec 2015
$294.00K
-

FAQ

  • What is the all-time high annual accounts receivable for Cogent Biosciences, Inc.?
  • What is the all-time high quarterly accounts receivable for Cogent Biosciences, Inc.?

What is the all-time high annual accounts receivable for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high annual accounts receivable is $2.00M

What is the all-time high quarterly accounts receivable for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high quarterly accounts receivable is $2.04M
On this page